October 26, 2016 9:06 AM ET


Company Overview of Drais Pharmaceuticals, Inc.

Executive Profile

Donna L. Tempel Ph.D., M.B.A.

Co-Founder, Chief Executive Officer, President and Director, Drais Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Donna L. Tempel, PhD, MBA is a co-founder of Drais Pharmaceuticals, Inc. in 2007 and serves as its Chief Executive Officer and President. Dr. Tempel served as Secretary of BioNJ Inc. She Co-founded AkaRx Inc. in 2005 and served as its Chief Operating Officer. She served as Vice President of Project Management of Yamanouchi Pharma America and was responsible for overseeing the conduct of all clinical development programs including the programs of Vesicare® and Vaprisol®. ...

Corporate Headquarters

520 US Highway 22
Bridgewater, New Jersey 08807

United States

Phone: 908-895-1200
Fax: 908-895-1201

Board Members Memberships

Vice Chairman
Co-Founder, Chief Executive Officer, President and Director


Icahn School of Medicine at Mount Sinai
Fairleigh Dickinson University
Hunter College, CUNY

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Drais Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.